Biotechnology
The Biotechnology industry has a total of 656 stocks, with a combined market cap of $829.42 billion and total revenue of $94.68 billion.
Market Cap
829.42B
Revenue
94.68B
Profits
-42.28B
PE Ratio
n/a
Profit Margin
-44.66%
Dividend Yield
0.01%
656 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.46B | 2.30% | 569,201 | 10.63B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.85B | 2.05% | 321,705 | 13.85B |
| 3 | ARGX | argenx SE | 40.62B | 0.01% | 147,190 | 1.91B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.61B | 5.13% | 334,551 | 2.09B |
| 5 | BNTX | BioNTech SE | 27.33B | 1.41% | 281,329 | 3.39B |
| 6 | ONC | BeiGene, Ltd. | 21.53B | 0.52% | 201,403 | 3.35B |
| 7 | RPRX | Royalty Pharma plc | 18.10B | 2.30% | 2,401,754 | 2.27B |
| 8 | UTHR | United Therapeutics Corporation | 16.21B | -0.43% | 124,029 | 2.76B |
| 9 | INCY | Incyte Corporation | 13.97B | 0.82% | 374,984 | 4.08B |
| 10 | GMAB | Genmab A/S | 13.79B | -5.87% | 1,213,334 | 2.97B |
| 11 | MRNA | Moderna, Inc. | 13.44B | 1.33% | 4,311,021 | 5.08B |
| 12 | SMMT | Summit Therapeutics Inc. | 12.75B | 3.87% | 1,126,360 | - |
| 13 | INSM | Insmed Incorporated | 12.50B | 2.31% | 820,522 | 342.96M |
| 14 | TECH | Bio-Techne Corporation | 12.04B | 1.41% | 313,249 | 1.17B |
| 15 | BMRN | BioMarin Pharmaceutical Inc. | 11.92B | -1.98% | 1,168,342 | 2.75B |
| 16 | SRPT | Sarepta Therapeutics, Inc. | 11.36B | 0.13% | 192,648 | 1.64B |
| 17 | PCVX | Vaxcyte, Inc. | 10.78B | 10.71% | 895,234 | - |
| 18 | EXEL | Exelixis, Inc. | 10.49B | 3.03% | 951,829 | 2.08B |
| 19 | ROIV | Roivant Sciences Ltd. | 8.06B | 1.23% | 1,386,902 | 129.13M |
| 20 | ASND | Ascendis Pharma A/S | 8.03B | 2.07% | 84,500 | 365.19M |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 7.43B | -0.04% | 168,155 | 3.99B |
| 22 | RVMD | Revolution Medicines, Inc. | 7.36B | -0.05% | 1,190,861 | 742.00K |
| 23 | HALO | Halozyme Therapeutics, Inc. | 7.00B | 2.15% | 594,021 | 947.36M |
| 24 | BPMC | Blueprint Medicines Corporation | 6.75B | 3.53% | 484,955 | 434.42M |
| 25 | BBIO | BridgeBio Pharma, Inc. | 6.60B | -1.85% | 2,346,486 | 217.77M |
| 26 | MDGL | Madrigal Pharmaceuticals, Inc. | 5.92B | -1.00% | 363,996 | 76.81M |
| 27 | LEGN | Legend Biotech Corporation | 5.77B | -0.60% | 301,161 | 520.18M |
| 28 | CYTK | Cytokinetics, Incorporated | 5.58B | 4.57% | 493,300 | 3.22M |
| 29 | CORT | Corcept Therapeutics Incorporated | 5.55B | 2.47% | 155,422 | 628.56M |
| 30 | NUVL | Nuvalent, Inc. | 5.40B | 4.95% | 185,948 | - |
| 31 | TLX | Telix Pharmaceuticals Limited | 5.20B | 0.24% | 791 | 430.80M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 5.20B | 0.67% | 668,067 | 803.07M |
| 33 | AXSM | Axsome Therapeutics, Inc. | 4.43B | 8.10% | 364,273 | 338.46M |
| 34 | TGTX | TG Therapeutics, Inc. | 4.29B | 0.49% | 1,611,003 | 264.79M |
| 35 | KRYS | Krystal Biotech, Inc. | 4.16B | 1.37% | 70,917 | 241.52M |
| 36 | VRNA | Verona Pharma plc | 4.06B | 2.48% | 518,671 | 5.62M |
| 37 | SRRK | Scholar Rock Holding Corporation | 4.04B | 3.91% | 575,258 | - |
| 38 | ADMA | ADMA Biologics, Inc. | 3.94B | 2.02% | 1,368,330 | 382.81M |
| 39 | RARE | Ultragenyx Pharmaceutical Inc. | 3.88B | 5.17% | 460,411 | 522.75M |
| 40 | VKTX | Viking Therapeutics, Inc. | 3.79B | 0.21% | 2,261,221 | - |
| 41 | BHVN | Biohaven Ltd. | 3.66B | 1.64% | 415,707 | - |
| 42 | APLS | Apellis Pharmaceuticals, Inc. | 3.64B | 5.60% | 820,053 | 715.22M |
| 43 | IMVT | Immunovant, Inc. | 3.56B | 5.90% | 457,544 | - |
| 44 | ACLX | Arcellx, Inc. | 3.51B | 0.53% | 324,867 | 155.82M |
| 45 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.39B | 2.75% | 842,550 | 1.04M |
| 46 | CRSP | CRISPR Therapeutics AG | 3.36B | 2.63% | 1,156,022 | 202.83M |
| 47 | RNA | Avidity Biosciences, Inc. | 3.30B | 2.14% | 446,149 | 10.12M |
| 48 | PTCT | PTC Therapeutics, Inc. | 3.26B | 1.12% | 206,958 | 900.66M |
| 49 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.26B | -1.76% | 198,109 | 112.53M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 3.07B | 1.69% | 137,777 | - |
| 51 | DNLI | Denali Therapeutics Inc. | 2.99B | 10.99% | 592,029 | - |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 2.90B | 3.02% | 519,228 | 929.24M |
| 53 | MLTX | MoonLake Immunotherapeutics | 2.89B | -1.38% | 229,302 | - |
| 54 | VCEL | Vericel Corporation | 2.89B | -0.15% | 680,081 | 226.84M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 2.78B | 0.92% | 1,252,651 | 493.67M |
| 56 | KYMR | Kymera Therapeutics, Inc. | 2.75B | 5.93% | 280,883 | 87.56M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 2.72B | 4.43% | 780,951 | - |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.72B | 2.75% | 588,540 | 460.48M |
| 59 | MRUS | Merus N.V. | 2.69B | 0.90% | 264,767 | 35.93M |
| 60 | ZLAB | Zai Lab Limited | 2.66B | 1.36% | 227,245 | 355.75M |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 2.55B | 0.72% | 273,693 | 33.59M |
| 62 | JANX | Janux Therapeutics, Inc. | 2.54B | -3.04% | 214,614 | 13.05M |
| 63 | SWTX | SpringWorks Therapeutics, Inc. | 2.52B | 4.14% | 942,128 | 135.49M |
| 64 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.33B | 3.60% | 753,616 | 3.55M |
| 65 | APGE | Apogee Therapeutics, Inc. | 2.28B | 2.01% | 182,013 | - |
| 66 | PTGX | Protagonist Therapeutics, Inc. | 2.28B | 4.27% | 326,011 | 323.80M |
| 67 | MIRM | Mirum Pharmaceuticals, Inc. | 2.21B | 6.42% | 203,622 | 307.03M |
| 68 | VERA | Vera Therapeutics, Inc. | 2.16B | -1.56% | 393,676 | - |
| 69 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | 0.92% | 194,122 | 681.88M |
| 70 | LGND | Ligand Pharmaceuticals Incorporated | 2.05B | -0.25% | 42,349 | 152.42M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.03B | 3.08% | 168,811 | 3.92M |
| 72 | CNTA | Centessa Pharmaceuticals plc | 2.02B | 3.17% | 65,827 | 6.85M |
| 73 | SLNO | Soleno Therapeutics, Inc. | 1.99B | 8.33% | 232,693 | - |
| 74 | CGON | CG Oncology, Inc. | 1.98B | 4.68% | 369,303 | 684.00K |
| 75 | AGIO | Agios Pharmaceuticals, Inc. | 1.91B | 0.39% | 195,047 | 32.87M |
| 76 | MESO | Mesoblast Limited | 1.90B | 1.59% | 372,032 | 5.90M |
| 77 | RXRX | Recursion Pharmaceuticals, Inc. | 1.85B | 1.92% | 7,998,454 | 65.18M |
| 78 | BEAM | Beam Therapeutics Inc. | 1.83B | -1.13% | 952,947 | 349.64M |
| 79 | GERN | Geron Corporation | 1.81B | 2.04% | 2,701,451 | 29.48M |
| 80 | IOVA | Iovance Biotherapeutics, Inc. | 1.79B | -0.08% | 5,201,557 | 90.86M |
| 81 | IRON | Disc Medicine, Inc. | 1.77B | 3.10% | 157,066 | - |
| 82 | WVE | Wave Life Sciences Ltd. | 1.73B | 1.89% | 342,164 | 53.61M |
| 83 | TARS | Tarsus Pharmaceuticals, Inc. | 1.72B | 1.58% | 432,298 | 129.62M |
| 84 | BLTE | Belite Bio, Inc | 1.70B | 1.08% | 34,405 | - |
| 85 | MNKD | MannKind Corporation | 1.67B | 0.58% | 691,645 | 267.20M |
| 86 | IBRX | ImmunityBio, Inc. | 1.63B | 1.08% | 2,262,232 | 7.33M |
| 87 | ARQT | Arcutis Biotherapeutics, Inc. | 1.61B | 3.46% | 814,651 | 138.71M |
| 88 | FTRE | Fortrea Holdings Inc. | 1.61B | 1.53% | 400,335 | 2.98B |
| 89 | GLPG | Galapagos NV | 1.59B | -0.96% | 134,143 | 290.09M |
| 90 | TVTX | Travere Therapeutics, Inc. | 1.57B | 5.74% | 478,477 | 203.45M |
| 91 | DYN | Dyne Therapeutics, Inc. | 1.57B | 2.85% | 1,171,722 | - |
| 92 | AKRO | Akero Therapeutics, Inc. | 1.54B | 0.82% | 344,216 | - |
| 93 | GPCR | Structure Therapeutics Inc. | 1.53B | 5.32% | 560,025 | - |
| 94 | CLDX | Celldex Therapeutics, Inc. | 1.52B | -0.31% | 569,579 | 9.98M |
| 95 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.51B | 0.90% | 920,238 | 412.58M |
| 96 | IMCR | Immunocore Holdings plc | 1.46B | 1.86% | 580,012 | 296.31M |
| 97 | VIR | Vir Biotechnology, Inc. | 1.45B | 3.28% | 1,348,720 | 78.62M |
| 98 | NRIX | Nurix Therapeutics, Inc. | 1.40B | 6.40% | 320,457 | 56.42M |
| 99 | NVAX | Novavax, Inc. | 1.39B | 1.76% | 2,393,610 | 885.19M |
| 100 | XNCR | Xencor, Inc. | 1.36B | 1.47% | 261,780 | 85.16M |
| 101 | VRDN | Viridian Therapeutics, Inc. | 1.34B | 0.56% | 518,979 | 302.00K |
| 102 | RCUS | Arcus Biosciences, Inc. | 1.30B | 2.89% | 174,781 | 263.00M |
| 103 | MDXG | MiMedx Group, Inc. | 1.29B | 2.03% | 181,641 | 342.80M |
| 104 | ARDX | Ardelyx, Inc. | 1.28B | -3.56% | 2,120,435 | 251.85M |
| 105 | OCUL | Ocular Therapeutix, Inc. | 1.27B | 2.80% | 254,850 | 61.44M |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 1.26B | 2.95% | 91,284 | 1.61M |
| 107 | SYRE | Spyre Therapeutics, Inc. | 1.25B | 2.07% | 184,726 | - |
| 108 | ARVN | Arvinas, Inc. | 1.23B | 3.72% | 351,954 | 161.10M |
| 109 | DAWN | Day One Biopharmaceuticals, Inc. | 1.18B | 4.44% | 1,356,187 | 101.95M |
| 110 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.16B | 1.54% | 915,976 | 276.92M |
| 111 | INVA | Innoviva, Inc. | 1.14B | 2.74% | 348,280 | 352.75M |
| 112 | SPRY | ARS Pharmaceuticals, Inc. | 1.12B | 1.06% | 941,219 | 2.57M |
| 113 | ELVN | Enliven Therapeutics, Inc. | 1.10B | 10.22% | 245,279 | - |
| 114 | AUPH | Aurinia Pharmaceuticals Inc. | 1.10B | 1.79% | 539,899 | 220.36M |
| 115 | SNDX | Syndax Pharmaceuticals, Inc. | 1.09B | 1.35% | 246,910 | 16.00M |
| 116 | ADPT | Adaptive Biotechnologies Corporation | 1.04B | 15.98% | 1,684,720 | 177.28M |
| 117 | BCYC | Bicycle Therapeutics plc | 1.00B | -1.92% | 102,292 | 36.90M |
| 118 | NTLA | Intellia Therapeutics, Inc. | 996.64M | 0.52% | 1,816,175 | 43.09M |
| 119 | RCKT | Rocket Pharmaceuticals, Inc. | 983.13M | 3.40% | 1,027,668 | - |
| 120 | LQDA | Liquidia Corporation | 976.71M | 1.58% | 267,419 | 15.61M |
| 121 | AVXL | Anavex Life Sciences Corp. | 955.02M | 7.55% | 991,053 | - |
| 122 | ZYME | Zymeworks Inc. | 947.07M | 0.95% | 147,477 | 62.20M |
| 123 | OCS | Oculis Holding AG | 923.21M | -1.92% | 127,166 | 1.03M |
| 124 | GYRE | Gyre Therapeutics, Inc. | 920.01M | 1.90% | 58,420 | 105.03M |
| 125 | CVAC | CureVac N.V. | 910.71M | 3.05% | 540,870 | 70.57M |
| 126 | TYRA | Tyra Biosciences, Inc. | 901.09M | 7.47% | 180,581 | - |
| 127 | COGT | Cogent Biosciences, Inc. | 888.11M | 9.09% | 1,728,239 | - |
| 128 | ABCL | AbCellera Biologics Inc. | 884.62M | 8.12% | 3,114,620 | 32.96M |
| 129 | PHVS | Pharvaris N.V. | 877.49M | 1.13% | 16,175 | - |
| 130 | NUVB | Nuvation Bio Inc. | 866.66M | -0.58% | 1,579,298 | 2.16M |
| 131 | AVBP | ArriVent BioPharma, Inc. | 842.26M | 0.58% | 32,453 | - |
| 132 | REPL | Replimune Group, Inc. | 803.42M | -0.48% | 251,857 | - |
| 133 | CDMO | Avid Bioservices, Inc. | 792.83M | -0.20% | 2,175,372 | 150.45M |
| 134 | ORIC | ORIC Pharmaceuticals, Inc. | 752.60M | 7.62% | 693,634 | - |
| 135 | ETNB | 89bio, Inc. | 749.00M | 1.43% | 411,686 | - |
| 136 | SEPN | Septerna, Inc. | 745.52M | -1.00% | 32,736 | 981.00K |
| 137 | SANA | Sana Biotechnology, Inc. | 733.44M | -9.50% | 5,942,560 | - |
| 138 | PLRX | Pliant Therapeutics, Inc. | 720.51M | 5.34% | 202,629 | - |
| 139 | CRMD | CorMedix Inc. | 712.65M | 4.68% | 730,746 | 12.26M |
| 140 | BCAX | Bicara Therapeutics Inc. | 706.59M | 1.17% | 185,533 | - |
| 141 | PRTA | Prothena Corporation plc | 701.93M | 2.96% | 129,139 | 133.35M |
| 142 | IMTX | Immatics N.V. | 689.28M | -3.27% | 304,513 | 128.82M |
| 143 | QURE | uniQure N.V. | 674.61M | 4.61% | 749,360 | 28.59M |
| 144 | RLAY | Relay Therapeutics, Inc. | 661.18M | -9.09% | 2,599,888 | 10.01M |
| 145 | PHAR | Pharming Group N.V. | 638.97M | -2.31% | 871 | 285.75M |
| 146 | LENZ | LENZ Therapeutics, Inc. | 627.85M | 2.10% | 83,211 | - |
| 147 | UPB | Upstream Bio, Inc. | 621.18M | 3.39% | 74,167 | 2.21M |
| 148 | ABUS | Arbutus Biopharma Corporation | 618.69M | 2.67% | 380,474 | 6.74M |
| 149 | SVRA | Savara Inc. | 616.86M | 8.27% | 552,198 | - |
| 150 | AUTL | Autolus Therapeutics plc | 605.43M | 2.94% | 589,903 | 10.09M |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 605.26M | 2.89% | 271,641 | 5.37M |
| 152 | IMNM | Immunome, Inc. | 594.83M | 1.60% | 204,662 | 10.13M |
| 153 | TECX | Tectonic Therapeutic, Inc. | 593.35M | 5.84% | 48,341 | - |
| 154 | CGEM | Cullinan Therapeutics, Inc. | 591.59M | 1.50% | 354,157 | - |
| 155 | CAPR | Capricor Therapeutics, Inc. | 588.15M | 2.74% | 346,611 | 23.23M |
| 156 | OPT | Opthea Limited | 571.54M | -5.19% | 9,331 | 261.86K |
| 157 | KURA | Kura Oncology, Inc. | 556.40M | -1.45% | 603,360 | - |
| 158 | HUMA | Humacyte, Inc. | 555.85M | 4.85% | 1,584,499 | - |
| 159 | ERAS | Erasca, Inc. | 552.73M | 1.56% | 588,443 | - |
| 160 | CRGX | CARGO Therapeutics, Inc. | 540.83M | 5.10% | 126,707 | - |
| 161 | EYPT | EyePoint Pharmaceuticals, Inc. | 514.62M | 1.88% | 300,929 | 45.71M |
| 162 | DNA | Ginkgo Bioworks Holdings, Inc. | 499.77M | 9.99% | 898,706 | 217.95M |
| 163 | OMER | Omeros Corporation | 496.63M | -0.23% | 237,197 | - |
| 164 | STOK | Stoke Therapeutics, Inc. | 496.04M | 7.89% | 951,234 | 16.74M |
| 165 | MNMD | Mind Medicine (MindMed) Inc. | 489.49M | 4.38% | 920,017 | - |
| 166 | XERS | Xeris Biopharma Holdings, Inc. | 486.01M | 1.88% | 801,983 | 187.36M |
| 167 | RAPP | Rapport Therapeutics, Inc. | 482.26M | 3.90% | 34,584 | - |
| 168 | MLYS | Mineralys Therapeutics, Inc. | 481.76M | 6.14% | 83,479 | - |
| 169 | TRML | Tourmaline Bio, Inc. | 479.90M | 0.62% | 96,534 | - |
| 170 | RNAC | Cartesian Therapeutics, Inc. | 474.63M | 2.39% | 38,930 | 47.94M |
| 171 | MREO | Mereo BioPharma Group plc | 471.66M | -0.49% | 787,875 | 1.00M |
| 172 | ANNX | Annexon, Inc. | 465.81M | -3.53% | 700,906 | - |
| 173 | PHAT | Phathom Pharmaceuticals, Inc. | 463.60M | -0.15% | 298,073 | 26.27M |
| 174 | PROK | ProKidney Corp. | 462.28M | 0.32% | 259,388 | - |
| 175 | ANAB | AnaptysBio, Inc. | 458.56M | 1.07% | 174,930 | 57.17M |
| 176 | ARCT | Arcturus Therapeutics Holdings Inc. | 457.37M | 1.78% | 133,838 | 160.40M |
| 177 | ALT | Altimmune, Inc. | 455.92M | 2.89% | 1,230,631 | 52.00K |
| 178 | VERV | Verve Therapeutics, Inc. | 453.37M | 2.00% | 486,707 | 24.40M |
| 179 | URGN | UroGen Pharma Ltd. | 451.32M | 7.70% | 350,562 | 89.36M |
| 180 | MGTX | MeiraGTx Holdings plc | 450.95M | - | 131,912 | 13.93M |
| 181 | SAGE | Sage Therapeutics, Inc. | 446.56M | -1.88% | 2,166,017 | 106.40M |
| 182 | TRDA | Entrada Therapeutics, Inc. | 440.44M | -0.40% | 47,705 | 215.23M |
| 183 | KOD | Kodiak Sciences Inc. | 438.39M | 9.87% | 339,230 | - |
| 184 | GHRS | GH Research PLC | 433.13M | 1.65% | 13,203 | - |
| 185 | ATXS | Astria Therapeutics, Inc. | 431.16M | 3.66% | 280,100 | - |
| 186 | TBPH | Theravance Biopharma, Inc. | 425.85M | 1.52% | 53,478 | 63.19M |
| 187 | MBX | MBX Biosciences, Inc. | 422.40M | 4.98% | 38,173 | - |
| 188 | KROS | Keros Therapeutics, Inc. | 421.99M | -16.53% | 8,293,845 | 651.00K |
| 189 | ZVRA | Zevra Therapeutics, Inc. | 415.80M | 1.17% | 97,101 | 24.49M |
| 190 | ALMS | Alumis Inc. | 413.77M | -0.46% | 22,333 | - |
| 191 | PRTC | PureTech Health plc | 411.08M | 4.99% | 8,254 | 468.00K |
| 192 | CELC | Celcuity Inc. | 404.53M | 3.47% | 152,686 | - |
| 193 | OLMA | Olema Pharmaceuticals, Inc. | 397.73M | 4.28% | 694,653 | - |
| 194 | TERN | Terns Pharmaceuticals, Inc. | 397.09M | 2.30% | 737,927 | - |
| 195 | ABVX | ABIVAX Société Anonyme | 395.12M | 3.66% | 149,229 | 9.68M |
| 196 | OABI | OmniAb, Inc. | 392.69M | 1.72% | 130,941 | 20.41M |
| 197 | CDXS | Codexis, Inc. | 390.41M | 5.91% | 391,198 | 64.45M |
| 198 | ALLO | Allogene Therapeutics, Inc. | 388.94M | -3.39% | 1,586,557 | 43.00K |
| 199 | AURA | Aura Biosciences, Inc. | 383.13M | 1.46% | 31,437 | - |
| 200 | ENGN | enGene Holdings Inc. | 372.13M | -3.69% | 75,408 | - |
| 201 | KALV | KalVista Pharmaceuticals, Inc. | 371.13M | 1.49% | 77,257 | - |
| 202 | GLUE | Monte Rosa Therapeutics, Inc. | 365.54M | 7.01% | 943,383 | 14.98M |
| 203 | RGNX | REGENXBIO Inc. | 358.95M | 2.77% | 895,118 | 84.33M |
| 204 | NMRA | Neumora Therapeutics, Inc. | 357.86M | -2.85% | 1,551,469 | - |
| 205 | PRME | Prime Medicine, Inc. | 356.63M | 3.52% | 546,830 | 800.00K |
| 206 | KRRO | Korro Bio, Inc. | 351.40M | 1.35% | 42,726 | - |
| 207 | VALN | Valneva SE | 350.68M | 1.17% | 36,600 | 176.82M |
| 208 | RVNC | Revance Therapeutics, Inc. | 346.70M | 0.46% | 280,137 | 256.95M |
| 209 | ZBIO | Zenas BioPharma, Inc. | 338.93M | 1.12% | 20,512 | - |
| 210 | XOMA | XOMA Royalty Corporation | 334.75M | 6.36% | 52,814 | 21.61M |
| 211 | CTNM | Contineum Therapeutics, Inc. | 333.82M | 1.41% | 29,004 | - |
| 212 | TSHA | Taysha Gene Therapies, Inc. | 333.03M | 0.31% | 744,443 | 9.92M |
| 213 | PGEN | Precigen, Inc. | 328.31M | 3.32% | 675,706 | 3.96M |
| 214 | CRVS | Corvus Pharmaceuticals, Inc. | 321.93M | -1.76% | 306,728 | - |
| 215 | ABSI | Absci Corporation | 321.02M | 3.14% | 2,511,208 | 4.21M |
| 216 | CMPX | Compass Therapeutics, Inc. | 315.08M | 14.50% | 1,246,417 | 850.00K |
| 217 | RIGL | Rigel Pharmaceuticals, Inc. | 313.46M | 6.62% | 78,203 | 157.37M |
| 218 | CMRX | Chimerix, Inc. | 299.49M | -1.19% | 1,128,993 | 159.00K |
| 219 | TRVI | Trevi Therapeutics, Inc. | 293.24M | -2.93% | 204,325 | - |
| 220 | ALDX | Aldeyra Therapeutics, Inc. | 288.52M | 3.09% | 192,338 | - |
| 221 | YMAB | Y-mAbs Therapeutics, Inc. | 287.99M | 1.58% | 192,497 | 84.55M |
| 222 | IMMP | Immutep Limited | 285.23M | 0.26% | 53,663 | 2.56M |
| 223 | TNGX | Tango Therapeutics, Inc. | 285.19M | 1.34% | 392,889 | 43.38M |
| 224 | VYGR | Voyager Therapeutics, Inc. | 285.15M | 3.37% | 241,176 | 163.78M |
| 225 | ITOS | iTeos Therapeutics, Inc. | 281.49M | 0.59% | 135,046 | 35.00M |
| 226 | ATYR | aTyr Pharma, Inc. | 281.20M | 1.82% | 442,823 | 235.00K |
| 227 | CCCC | C4 Therapeutics, Inc. | 276.72M | 4.82% | 732,702 | 33.67M |
| 228 | DRUG | Bright Minds Biosciences Inc. | 271.10M | 4.03% | 58,235 | - |
| 229 | NGNE | Neurogene Inc. | 269.61M | 1.45% | 23,382 | 925.00K |
| 230 | AVIR | Atea Pharmaceuticals, Inc. | 268.59M | 0.95% | 173,568 | - |
| 231 | THRD | Third Harmonic Bio, Inc. | 268.10M | -0.67% | 195,466 | - |
| 232 | RZLT | Rezolute, Inc. | 267.99M | -2.01% | 116,701 | - |
| 233 | DRTS | Alpha Tau Medical Ltd. | 266.74M | -4.88% | 147,504 | - |
| 234 | ACIU | AC Immune SA | 261.20M | 1.15% | 64,583 | 48.51M |
| 235 | VNDA | Vanda Pharmaceuticals Inc. | 254.81M | -0.23% | 198,550 | 190.86M |
| 236 | SLN | Silence Therapeutics plc | 253.07M | -4.46% | 119,614 | 21.77M |
| 237 | BNTC | Benitec Biopharma Inc. | 248.18M | 2.99% | 45,551 | - |
| 238 | LXRX | Lexicon Pharmaceuticals, Inc. | 245.67M | -1.78% | 2,076,311 | 5.23M |
| 239 | NAUT | Nautilus Biotechnology, Inc. | 239.93M | 2.73% | 53,911 | - |
| 240 | ATAI | Atai Life Sciences N.V. | 239.12M | 7.14% | 908,837 | 331.00K |
| 241 | FHTX | Foghorn Therapeutics Inc. | 237.94M | 0.94% | 30,302 | 25.52M |
| 242 | PRQR | ProQR Therapeutics N.V. | 237.37M | 1.77% | 120,675 | 20.51M |
| 243 | ELDN | Eledon Pharmaceuticals, Inc. | 237.16M | 7.01% | 127,426 | - |
| 244 | DSGN | Design Therapeutics, Inc. | 235.54M | 3.48% | 104,422 | - |
| 245 | VSTM | Verastem, Inc. | 234.55M | 4.56% | 333,871 | 10.00M |
| 246 | FDMT | 4D Molecular Therapeutics, Inc. | 229.98M | 1.95% | 347,273 | 17.00K |
| 247 | DMAC | DiaMedica Therapeutics Inc. | 229.62M | 6.97% | 33,668 | - |
| 248 | ABEO | Abeona Therapeutics Inc. | 229.09M | 3.54% | 205,166 | - |
| 249 | HRTX | Heron Therapeutics, Inc. | 228.90M | 2.38% | 365,502 | 137.74M |
| 250 | CADL | Candel Therapeutics, Inc. | 227.00M | -10.84% | 1,462,188 | - |
| 251 | AMLX | Amylyx Pharmaceuticals, Inc. | 225.01M | 5.59% | 470,276 | 196.49M |
| 252 | CDTX | Cidara Therapeutics, Inc. | 223.86M | -2.18% | 56,369 | 44.65M |
| 253 | SGMO | Sangamo Therapeutics, Inc. | 223.25M | 4.39% | 4,554,587 | 52.29M |
| 254 | FULC | Fulcrum Therapeutics, Inc. | 220.88M | 0.86% | 321,326 | 80.87M |
| 255 | TVGN | Tevogen Bio Holdings Inc. | 217.08M | 0.01% | 460,930 | - |
| 256 | LRMR | Larimar Therapeutics, Inc. | 213.75M | 1.82% | 125,507 | - |
| 257 | OBIO | Orchestra BioMed Holdings, Inc. | 209.46M | 4.56% | 22,465 | 2.65M |
| 258 | MDWD | MediWound Ltd. | 209.11M | 1.89% | 41,114 | 19.72M |
| 259 | OCGN | Ocugen, Inc. | 208.44M | -2.43% | 4,574,256 | 4.70M |
| 260 | GOSS | Gossamer Bio, Inc. | 205.85M | 7.07% | 757,755 | 105.32M |
| 261 | SLRN | Acelyrin, Inc. | 204.16M | -3.10% | 611,045 | - |
| 262 | MOLN | Molecular Partners AG | 201.60M | 4.24% | 10,824 | 7.11M |
| 263 | MGNX | MacroGenics, Inc. | 196.14M | 2.80% | 293,450 | 141.33M |
| 264 | IVA | Inventiva S.A. | 195.32M | -0.91% | 908 | 20.65M |
| 265 | ZNTL | Zentalis Pharmaceuticals, Inc. | 195.27M | 3.59% | 844,190 | 40.56M |
| 266 | INBX | Inhibrx Biosciences, Inc. | 192.89M | 4.59% | 54,612 | 1.57M |
| 267 | HURA | TuHURA Biosciences, Inc. | 190.37M | -1.32% | 88,773 | - |
| 268 | CYBN | Cybin Inc. | 182.41M | 3.28% | 110,156 | - |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 181.42M | 1.50% | 31,602 | 1.00 |
| 270 | LXEO | Lexeo Therapeutics, Inc. | 181.20M | -5.52% | 71,443 | - |
| 271 | ARTV | Artiva Biotherapeutics, Inc. | 178.65M | 5.52% | 25,355 | 2.60M |
| 272 | ACRV | Acrivon Therapeutics, Inc. | 176.54M | 1.98% | 39,976 | - |
| 273 | CGEN | Compugen Ltd. | 176.39M | -1.50% | 749,467 | 59.85M |
| 274 | SCPH | scPharmaceuticals Inc. | 175.64M | 3.85% | 190,480 | 30.28M |
| 275 | LYEL | Lyell Immunopharma, Inc. | 175.00M | 4.26% | 330,500 | 63.00K |
| 276 | CRDF | Cardiff Oncology, Inc. | 174.62M | 3.80% | 537,591 | 688.00K |
| 277 | CLLS | Cellectis S.A. | 169.93M | -1.79% | 195,221 | 36.04M |
| 278 | GNFT | Genfit S.A. | 169.40M | - | 395 | 86.23M |
| 279 | VXRT | Vaxart, Inc. | 169.31M | 1.82% | 1,045,682 | 16.76M |
| 280 | NKTR | Nektar Therapeutics | 167.89M | 1.13% | 566,867 | 93.14M |
| 281 | CHRS | Coherus BioSciences, Inc. | 167.06M | 0.69% | 797,014 | 304.34M |
| 282 | ADCT | ADC Therapeutics SA | 165.82M | 0.29% | 323,297 | 70.72M |
| 283 | RAPT | RAPT Therapeutics, Inc. | 163.97M | 10.45% | 735,988 | - |
| 284 | ALEC | Alector, Inc. | 162.57M | 1.53% | 550,162 | 61.51M |
| 285 | VOR | Vor Biopharma Inc. | 161.91M | -2.99% | 306,900 | - |
| 286 | ACTU | Actuate Therapeutics, Inc. | 161.72M | 8.24% | 43,178 | - |
| 287 | CKPT | Checkpoint Therapeutics, Inc. | 160.12M | 3.44% | 421,779 | 47.00K |
| 288 | PLX | Protalix BioTherapeutics, Inc. | 160.10M | -0.26% | 185,279 | 45.67M |
| 289 | GLSI | Greenwich LifeSciences, Inc. | 158.39M | -0.08% | 10,867 | - |
| 290 | FENC | Fennec Pharmaceuticals Inc. | 156.16M | 0.79% | 2,725 | 49.35M |
| 291 | NKTX | Nkarta, Inc. | 155.96M | - | 521,671 | - |
| 292 | TCRX | TScan Therapeutics, Inc. | 152.00M | 2.28% | 48,864 | 9.36M |
| 293 | IPHA | Innate Pharma S.A. | 151.83M | -7.02% | 67,153 | 36.20M |
| 294 | FATE | Fate Therapeutics, Inc. | 150.91M | 5.58% | 1,236,330 | 13.45M |
| 295 | PBYI | Puma Biotechnology, Inc. | 150.70M | -0.65% | 566,318 | 243.57M |
| 296 | IFRX | InflaRx N.V. | 147.84M | 7.30% | 134,766 | 187.93K |
| 297 | STRO | Sutro Biopharma, Inc. | 147.60M | 4.07% | 389,504 | 160.96M |
| 298 | BMEA | Biomea Fusion, Inc. | 147.49M | -1.93% | 405,119 | - |
| 299 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 146.88M | 5.33% | 88,873 | - |
| 300 | NBTX | Nanobiotix S.A. | 144.35M | 1.73% | 2,043 | 45.22M |
| 301 | KYTX | Kyverna Therapeutics, Inc. | 144.19M | 0.30% | 70,200 | - |
| 302 | ADAP | Adaptimmune Therapeutics plc | 143.19M | -5.14% | 1,038,491 | 175.04M |
| 303 | CRBU | Caribou Biosciences, Inc. | 141.26M | - | 1,000,315 | 11.48M |
| 304 | TELO | Telomir Pharmaceuticals, Inc. | 138.57M | 2.18% | 30,357 | - |
| 305 | VTYX | Ventyx Biosciences, Inc. | 137.53M | 0.26% | 476,812 | - |
| 306 | SEER | Seer, Inc. | 137.43M | 1.77% | 53,671 | 14.61M |
| 307 | TIL | Instil Bio, Inc. | 136.20M | 4.19% | 31,686 | - |
| 308 | SGMT | Sagimet Biosciences Inc. | 136.03M | 1.68% | 842,263 | - |
| 309 | MNPR | Monopar Therapeutics Inc. | 134.32M | 1.88% | 29,452 | - |
| 310 | CLYM | Climb Bio, Inc. | 133.10M | 5.88% | 290,956 | - |
| 311 | SAVA | Cassava Sciences, Inc. | 131.58M | 4.79% | 1,496,237 | - |
| 312 | MCRB | Seres Therapeutics, Inc. | 130.82M | -0.01% | 688,064 | 126.33M |
| 313 | MIST | Milestone Pharmaceuticals Inc. | 129.83M | - | 168,088 | - |
| 314 | INMB | INmune Bio, Inc. | 129.49M | -1.93% | 164,436 | 42.00K |
| 315 | RENB | Renovaro Inc. | 128.56M | -0.75% | 220,804 | - |
| 316 | CSBR | Champions Oncology, Inc. | 128.08M | -3.31% | 22,775 | 53.57M |
| 317 | SLDB | Solid Biosciences Inc. | 125.67M | 1.79% | 332,778 | - |
| 318 | LCTX | Lineage Cell Therapeutics, Inc. | 125.59M | 3.60% | 475,783 | 8.72M |
| 319 | TSVT | 2seventy bio, Inc. | 125.10M | 1.46% | 43,985 | 45.62M |
| 320 | ZURA | Zura Bio Limited | 123.73M | -2.82% | 231,939 | - |
| 321 | LPTX | Leap Therapeutics, Inc. | 122.62M | 3.56% | 250,633 | - |
| 322 | ANRO | Alto Neuroscience, Inc. | 121.23M | 1.24% | 61,032 | - |
| 323 | BDTX | Black Diamond Therapeutics, Inc. | 120.78M | -5.13% | 725,976 | - |
| 324 | ALGS | Aligos Therapeutics, Inc. | 117.88M | 5.69% | 182,113 | 6.00M |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 116.06M | 2.45% | 818,484 | - |
| 326 | XBIT | XBiotech Inc. | 114.62M | 1.35% | 10,785 | - |
| 327 | ACHV | Achieve Life Sciences, Inc. | 111.77M | 3.17% | 71,263 | - |
| 328 | FBRX | Forte Biosciences, Inc. | 108.62M | 16.21% | 34,909 | - |
| 329 | EPRX | Eupraxia Pharmaceuticals Inc. | 107.68M | -0.98% | 27,136 | - |
| 330 | CABA | Cabaletta Bio, Inc. | 107.32M | 0.26% | 543,791 | - |
| 331 | ATOS | Atossa Therapeutics, Inc. | 106.39M | -3.26% | 553,849 | - |
| 332 | MGX | Metagenomi, Inc. | 106.28M | 2.90% | 233,345 | 55.08M |
| 333 | VERU | Veru Inc. | 105.89M | -2.70% | 677,280 | 16.89M |
| 334 | NVCT | Nuvectis Pharma, Inc. | 105.88M | -2.84% | 60,773 | - |
| 335 | ENTA | Enanta Pharmaceuticals, Inc. | 103.21M | 0.62% | 261,607 | 67.64M |
| 336 | ABOS | Acumen Pharmaceuticals, Inc. | 101.53M | 8.33% | 682,975 | - |
| 337 | IGMS | IGM Biosciences, Inc. | 101.09M | -0.58% | 873,315 | 2.92M |
| 338 | EDIT | Editas Medicine, Inc. | 99.88M | 6.14% | 1,479,553 | 61.76M |
| 339 | TARA | Protara Therapeutics, Inc. | 96.62M | -6.89% | 292,553 | - |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 94.70M | -0.46% | 40,343 | - |
| 341 | HLVX | HilleVax, Inc. | 94.50M | -0.55% | 214,194 | - |
| 342 | MNOV | MediciNova, Inc. | 94.17M | 0.52% | 15,279 | - |
| 343 | COYA | Coya Therapeutics, Inc. | 93.65M | -0.80% | 46,967 | 9.55M |
| 344 | DBVT | DBV Technologies S.A. | 92.90M | 5.03% | 58,527 | 12.52M |
| 345 | INZY | Inozyme Pharma, Inc. | 92.18M | -4.97% | 523,701 | - |
| 346 | ASMB | Assembly Biosciences, Inc. | 92.04M | -1.76% | 39,305 | 28.33M |
| 347 | OSTX | OS Therapies Incorporated | 91.33M | 3.37% | 80,039 | - |
| 348 | ADVM | Adverum Biotechnologies, Inc. | 90.49M | 2.35% | 20,517 | 1.00M |
| 349 | IMUX | Immunic, Inc. | 88.89M | -1.32% | 353,363 | - |
| 350 | JSPR | Jasper Therapeutics, Inc. | 87.76M | -0.34% | 588,249 | - |
| 351 | IMAB | I-Mab | 87.21M | 2.88% | 98,763 | 3.31M |
| 352 | PEPG | PepGen Inc. | 87.03M | -1.84% | 48,122 | - |
| 353 | GUTS | Fractyl Health, Inc. | 86.66M | 0.65% | 146,589 | 97.00K |
| 354 | ENTX | Entera Bio Ltd. | 86.19M | -0.85% | 33,686 | 99.00K |
| 355 | ALXO | ALX Oncology Holdings Inc. | 85.97M | 2.52% | 333,544 | - |
| 356 | OKUR | OnKure Therapeutics, Inc. | 85.24M | 0.16% | 51,640 | - |
| 357 | PYXS | Pyxis Oncology, Inc. | 85.04M | -0.69% | 751,617 | 16.15M |
| 358 | SKYE | Skye Bioscience, Inc. | 84.23M | 1.70% | 32,521 | - |
| 359 | GNLX | Genelux Corporation | 82.53M | 1.26% | 25,995 | 8.00K |
| 360 | TLSA | Tiziana Life Sciences Ltd | 81.81M | 3.45% | 267,681 | - |
| 361 | CUE | Cue Biopharma, Inc. | 81.09M | 4.92% | 105,652 | 9.53M |
| 362 | VTGN | Vistagen Therapeutics, Inc. | 80.47M | 1.76% | 195,534 | 876.00K |
| 363 | RGLS | Regulus Therapeutics Inc. | 79.91M | -0.41% | 180,907 | - |
| 364 | APLT | Applied Therapeutics, Inc. | 79.86M | 7.27% | 2,358,617 | -212.00K |
| 365 | KPTI | Karyopharm Therapeutics Inc. | 79.70M | -0.25% | 289,329 | 148.44M |
| 366 | ADAG | Adagene Inc. | 79.24M | -1.65% | 8,381 | 815.75K |
| 367 | CAMP | Camp4 Therapeutics Corporation | 78.83M | 4.55% | 29,667 | - |
| 368 | THTX | Theratechnologies Inc. | 78.78M | 3.92% | 81,110 | 84.32M |
| 369 | XFOR | X4 Pharmaceuticals, Inc. | 78.76M | 1.32% | 1,418,071 | 1.12M |
| 370 | EPIX | ESSA Pharma Inc. | 78.57M | - | 27,205 | - |
| 371 | GALT | Galectin Therapeutics Inc. | 78.45M | 8.70% | 176,894 | - |
| 372 | BLUE | bluebird bio, Inc. | 78.07M | 0.25% | 56,281 | 53.12M |
| 373 | IPSC | Century Therapeutics, Inc. | 77.51M | -2.52% | 216,838 | 2.68M |
| 374 | MRSN | Mersana Therapeutics, Inc. | 77.36M | -1.23% | 4,004,429 | 34.84M |
| 375 | VIGL | Vigil Neuroscience, Inc. | 77.23M | 6.25% | 92,480 | - |
| 376 | ALLK | Allakos Inc. | 76.54M | -2.82% | 61,354 | - |
| 377 | QNCX | Quince Therapeutics, Inc. | 75.68M | 0.58% | 52,243 | - |
| 378 | GNTA | Genenta Science S.p.A. | 75.54M | -2.36% | 9,864 | - |
| 379 | CNTX | Context Therapeutics Inc. | 75.00M | 1.00% | 303,753 | - |
| 380 | ANL | Adlai Nortye Ltd. | 74.91M | 2.53% | 2,300 | 5.00M |
| 381 | ANIX | Anixa Biosciences, Inc. | 74.69M | 8.92% | 124,717 | - |
| 382 | AADI | Aadi Bioscience, Inc. | 74.68M | 1.17% | 132,704 | 25.07M |
| 383 | CBUS | Cibus, Inc. | 74.51M | 3.28% | 54,923 | 4.15M |
| 384 | ACET | Adicet Bio, Inc. | 74.21M | -0.95% | 109,109 | - |
| 385 | AGEN | Agenus Inc. | 73.64M | -0.18% | 114,486 | 160.43M |
| 386 | RANI | Rani Therapeutics Holdings, Inc. | 73.22M | -0.39% | 93,317 | - |
| 387 | PMVP | PMV Pharmaceuticals, Inc. | 72.45M | 3.70% | 142,996 | - |
| 388 | IKNA | Ikena Oncology, Inc. | 72.39M | -0.66% | 228,345 | 659.00K |
| 389 | ARMP | Armata Pharmaceuticals, Inc. | 72.37M | -0.74% | 857 | 5.47M |
| 390 | VANI | Vivani Medical, Inc. | 71.88M | 1.97% | 30,798 | - |
| 391 | ATRA | Atara Biotherapeutics, Inc. | 71.82M | 1.30% | 283,285 | 100.44M |
| 392 | AVTE | Aerovate Therapeutics, Inc. | 70.74M | -0.61% | 213,302 | - |
| 393 | CLSD | Clearside Biomedical, Inc. | 70.53M | 1.09% | 76,655 | 7.70M |
| 394 | FBLG | FibroBiologics, Inc. | 69.47M | 5.32% | 23,930 | - |
| 395 | BYSI | BeyondSpring Inc. | 68.51M | 3.03% | 7,763 | 1.88M |
| 396 | SLS | SELLAS Life Sciences Group, Inc. | 68.01M | 4.07% | 566,285 | - |
| 397 | ELTX | Elicio Therapeutics, Inc. | 67.89M | 1.61% | 15,125 | - |
| 398 | ABP | Abpro Holdings, Inc. | 67.80M | 4.84% | 12,609 | 122.00K |
| 399 | UNCY | Unicycive Therapeutics, Inc. | 66.44M | -3.18% | 968,139 | - |
| 400 | ANVS | Annovis Bio, Inc. | 65.67M | 1.93% | 116,301 | - |
| 401 | AVTX | Avalo Therapeutics, Inc. | 65.66M | -3.76% | 54,087 | 820.00K |
| 402 | CTMX | CytomX Therapeutics, Inc. | 65.26M | -0.84% | 1,292,251 | 126.62M |
| 403 | MURA | Mural Oncology plc | 63.02M | -0.81% | 143,999 | - |
| 404 | ONCY | Oncolytics Biotech Inc. | 62.81M | -4.65% | 30,633,584 | - |
| 405 | GBIO | Generation Bio Co. | 62.28M | 5.95% | 897,642 | 18.58M |
| 406 | HOWL | Werewolf Therapeutics, Inc. | 61.50M | 2.22% | 114,052 | 3.39M |
| 407 | IMRX | Immuneering Corporation | 60.86M | 0.51% | 968,946 | - |
| 408 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 60.13M | 13.80% | 1,081,481 | - |
| 409 | KRON | Kronos Bio, Inc. | 59.44M | 0.51% | 22,289 | 9.86M |
| 410 | FGEN | FibroGen, Inc. | 59.35M | 6.15% | 547,469 | 180.02M |
| 411 | VRCA | Verrica Pharmaceuticals Inc. | 58.15M | -2.07% | 129,026 | 9.21M |
| 412 | GANX | Gain Therapeutics, Inc. | 56.76M | 2.88% | 52,420 | - |
| 413 | PRLD | Prelude Therapeutics Incorporated | 56.14M | - | 48,997 | 3.00M |
| 414 | IMMX | Immix Biopharma, Inc. | 55.98M | 1.75% | 28,042 | - |
| 415 | BOLD | Boundless Bio, Inc. | 55.97M | 9.13% | 22,398 | - |
| 416 | CNTB | Connect Biopharma Holdings Limited | 55.81M | -4.72% | 6,225 | 24.12M |
| 417 | STTK | Shattuck Labs, Inc. | 55.14M | 3.13% | 22,748 | 6.44M |
| 418 | MAIA | MAIA Biotechnology, Inc. | 54.97M | -1.81% | 114,757 | - |
| 419 | NRXP | NRx Pharmaceuticals, Inc. | 54.88M | -10.78% | 936,760 | - |
| 420 | OVID | Ovid Therapeutics Inc. | 54.69M | 1.76% | 165,914 | 631.70K |
| 421 | OTLK | Outlook Therapeutics, Inc. | 54.67M | 1.62% | 384,387 | - |
| 422 | RPTX | Repare Therapeutics Inc. | 54.63M | 1.18% | 153,105 | 66.52M |
| 423 | PDSB | PDS Biotechnology Corporation | 53.12M | 2.16% | 77,788 | - |
| 424 | IOBT | IO Biotech, Inc. | 52.03M | -4.74% | 128,629 | - |
| 425 | FBIO | Fortress Biotech, Inc. | 51.21M | -2.11% | 232,520 | 81.50M |
| 426 | LSB | LakeShore Biopharma Co., Ltd | 49.99M | 0.77% | 5,467 | 79.42M |
| 427 | SPRO | Spero Therapeutics, Inc. | 49.06M | -7.63% | 438,098 | 106.46M |
| 428 | IVVD | Invivyd, Inc. | 48.88M | 0.96% | 811,055 | 11.56M |
| 429 | INO | Inovio Pharmaceuticals, Inc. | 48.15M | -1.34% | 288,494 | 203.41K |
| 430 | XLO | Xilio Therapeutics, Inc. | 47.91M | 0.93% | 146,098 | 4.62M |
| 431 | CELU | Celularity Inc. | 47.67M | 0.95% | 15,853 | 48.20M |
| 432 | ALVR | AlloVir, Inc. | 47.65M | 4.10% | 675,680 | - |
| 433 | ACHL | Achilles Therapeutics plc | 47.48M | -1.27% | 24,729 | - |
| 434 | NTRB | Nutriband Inc. | 46.65M | 0.96% | 6,512 | 2.02M |
| 435 | SER | Serina Therapeutics, Inc. | 46.11M | 0.20% | 30,668 | 3.16M |
| 436 | KZR | Kezar Life Sciences, Inc. | 45.89M | 1.29% | 45,872 | - |
| 437 | VTVT | vTv Therapeutics Inc. | 45.52M | 4.62% | 6,486 | 1.00M |
| 438 | ITRM | Iterum Therapeutics plc | 45.40M | 3.13% | 168,018 | - |
| 439 | DYAI | Dyadic International, Inc. | 45.27M | -2.55% | 95,170 | 3.36M |
| 440 | CLGN | CollPlant Biotechnologies Ltd. | 44.90M | 3.16% | 12,643 | 650.00K |
| 441 | ICCC | ImmuCell Corporation | 44.83M | -2.90% | 1,268 | 23.84M |
| 442 | ELEV | Elevation Oncology, Inc. | 42.79M | -7.25% | 2,367,654 | - |
| 443 | CALC | CalciMedica, Inc. | 42.47M | -0.94% | 15,745 | - |
| 444 | ANEB | Anebulo Pharmaceuticals, Inc. | 42.27M | -0.61% | 7,395 | - |
| 445 | VYNE | VYNE Therapeutics Inc. | 41.85M | 3.17% | 53,955 | 493.00K |
| 446 | TNXP | Tonix Pharmaceuticals Holding Corp. | 41.81M | -1.50% | 27,355,455 | 11.29M |
| 447 | ESLA | Estrella Immunopharma, Inc. | 41.60M | 5.48% | 3,514 | - |
| 448 | INTS | Intensity Therapeutics, Inc. | 41.38M | 5.38% | 46,019 | - |
| 449 | DTIL | Precision BioSciences, Inc. | 41.12M | -0.37% | 247,518 | 75.10M |
| 450 | BRNS | Barinthus Biotherapeutics plc | 41.03M | 5.15% | 38,768 | 14.97M |
| 451 | SRZN | Surrozen, Inc. | 40.20M | 10.55% | 8,110 | 10.00M |
| 452 | CASI | CASI Pharmaceuticals, Inc. | 39.74M | 0.20% | 15,627 | 22.06M |
| 453 | TPST | Tempest Therapeutics, Inc. | 39.23M | -2.19% | 762,011 | - |
| 454 | RADX | Radiopharm Theranostics Limited | 39.01M | 2.96% | 2,198 | 1.31M |
| 455 | BIVI | BioVie Inc. | 38.50M | 7.96% | 516,275 | - |
| 456 | QTTB | Q32 Bio Inc. | 37.88M | 1.31% | 47,436 | -14.66M |
| 457 | LTRN | Lantern Pharma Inc. | 37.85M | 0.57% | 14,521 | - |
| 458 | ATNM | Actinium Pharmaceuticals, Inc. | 37.75M | -0.82% | 67,773 | 81.00K |
| 459 | RLYB | Rallybio Corporation | 37.73M | 2.19% | 25,733 | 598.00K |
| 460 | ANTX | AN2 Therapeutics, Inc. | 37.05M | 1.64% | 32,353 | - |
| 461 | IRD | Opus Genetics, Inc. | 36.94M | 0.86% | 98,471 | 8.38M |
| 462 | CMMB | Chemomab Therapeutics Ltd. | 36.39M | 1.58% | 40,226 | - |
| 463 | PASG | Passage Bio, Inc. | 36.07M | -2.18% | 106,376 | - |
| 464 | GRCE | Grace Therapeutics, Inc. | 35.88M | 0.53% | 20,866 | - |
| 465 | LEXX | Lexaria Bioscience Corp. | 34.61M | 2.76% | 342,381 | 496.92K |
| 466 | OKYO | OKYO Pharma Limited | 34.51M | -1.92% | 31,847 | - |
| 467 | OMGA | Omega Therapeutics, Inc. | 34.06M | 3.03% | 84,851 | 8.10M |
| 468 | MLEC | Moolec Science SA | 33.48M | -1.03% | 2,968 | 5.63M |
| 469 | INKT | MiNK Therapeutics, Inc. | 32.73M | -2.65% | 63,930 | - |
| 470 | RNXT | RenovoRx, Inc. | 32.38M | 2.27% | 23,777 | - |
| 471 | KALA | KALA BIO, Inc. | 32.27M | 7.69% | 11,689 | - |
| 472 | SLGL | Sol-Gel Technologies Ltd. | 32.04M | -8.73% | 206,376 | 11.71M |
| 473 | SABS | SAB Biotherapeutics, Inc. | 31.84M | -2.82% | 25,812 | 1.51M |
| 474 | ATHE | Alterity Therapeutics Limited | 31.29M | -0.57% | 16,134 | 2.68M |
| 475 | LSTA | Lisata Therapeutics, Inc. | 31.07M | 1.66% | 30,192 | - |
| 476 | RAIN | Rain Enhancement Technologies Holdco, Inc. | 30.12M | -7.62% | 8,547 | - |
| 477 | MRNS | Marinus Pharmaceuticals, Inc. | 29.78M | 0.13% | 685,279 | 31.47M |
| 478 | UBX | Unity Biotechnology, Inc. | 29.49M | 2.34% | 174,970 | - |
| 479 | XCUR | Exicure, Inc. | 29.48M | 12.53% | 53,609 | 500.00K |
| 480 | CVKD | Cadrenal Therapeutics, Inc. | 29.27M | 2.70% | 14,124 | - |
| 481 | AKTX | Akari Therapeutics, Plc | 29.22M | 2.61% | 2,268 | - |
| 482 | CGTX | Cognition Therapeutics, Inc. | 29.20M | -1.55% | 486,437 | - |
| 483 | DARE | Daré Bioscience, Inc. | 28.97M | -0.30% | 12,490 | 1.88M |
| 484 | PMN | ProMIS Neurosciences, Inc. | 28.85M | -5.12% | 35,960 | - |
| 485 | CVM | CEL-SCI Corporation | 28.19M | -6.05% | 446,797 | - |
| 486 | CRIS | Curis, Inc. | 27.77M | 2.82% | 24,478 | 10.26M |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 26.81M | -2.53% | 38,046 | - |
| 488 | LGVN | Longeveron Inc. | 25.96M | -3.32% | 174,868 | 1.85M |
| 489 | BLRX | BioLineRx Ltd. | 25.90M | -13.01% | 6,769,140 | 21.99M |
| 490 | GDTC | CytoMed Therapeutics Limited | 25.85M | -0.44% | 26,618 | 330.25K |
| 491 | IBIO | iBio, Inc. | 25.72M | 2.98% | 117,332 | 175.00K |
| 492 | IGC | IGC Pharma, Inc. | 25.56M | 1.20% | 131,146 | 1.18M |
| 493 | LPCN | Lipocine Inc. | 25.26M | 2.67% | 25,415 | 7.92M |
| 494 | ENLV | Enlivex Therapeutics Ltd. | 25.18M | 0.44% | 74,166 | - |
| 495 | LVTX | LAVA Therapeutics N.V. | 25.02M | -2.94% | 15,376 | 7.35M |
| 496 | PLUR | Pluri Inc. | 24.86M | 0.68% | 670 | 598.00K |
| 497 | EQ | Equillium, Inc. | 24.53M | 0.49% | 27,936 | 45.91M |
| 498 | NRSN | NeuroSense Therapeutics Ltd. | 23.82M | - | 41,837 | - |
| 499 | CDIO | Cardio Diagnostics Holdings, Inc. | 23.66M | 2.52% | 423,160 | 35.69K |
| 500 | ERNA | Eterna Therapeutics Inc. | 23.63M | 0.41% | 15,220,180 | 598.00K |
| 501 | MRKR | Marker Therapeutics, Inc. | 23.38M | 3.15% | 26,058 | 5.40M |
| 502 | BCAB | BioAtla, Inc. | 23.22M | -3.96% | 561,141 | 11.00M |
| 503 | HOOK | HOOKIPA Pharma Inc. | 23.18M | 3.38% | 53,241 | 50.00M |
| 504 | NRXS | NeurAxis, Inc. | 22.52M | -1.59% | 12,430 | 2.46M |
| 505 | PTN | Palatin Technologies, Inc. | 22.28M | 1.79% | 163,371 | 2.38M |
| 506 | NXTC | NextCure, Inc. | 22.06M | 0.87% | 64,799 | - |
| 507 | PULM | Pulmatrix, Inc. | 21.80M | 1.19% | 6,202 | 10.01M |
| 508 | INAB | IN8bio, Inc. | 21.75M | -5.18% | 579,929 | - |
| 509 | OCEA | Ocean Biomedical, Inc. | 21.64M | -0.29% | 26,500 | - |
| 510 | TENX | Tenax Therapeutics, Inc. | 21.56M | -0.55% | 8,746 | - |
| 511 | PYPD | PolyPid Ltd. | 21.43M | 2.27% | 20,022 | - |
| 512 | TRAW | Traws Pharma, Inc. | 21.18M | 4.79% | 37,825 | 226.00K |
| 513 | GOVX | GeoVax Labs, Inc. | 21.04M | 5.69% | 300,445 | 3.09M |
| 514 | ATHA | Athira Pharma, Inc. | 20.95M | 1.84% | 58,538 | - |
| 515 | CARA | Cara Therapeutics, Inc. | 20.80M | -2.57% | 30,225 | 8.69M |
| 516 | APRE | Aprea Therapeutics, Inc. | 20.49M | 5.31% | 4,084 | 1.31M |
| 517 | COCP | Cocrystal Pharma, Inc. | 20.14M | -0.50% | 12,954 | - |
| 518 | BOLT | Bolt Biotherapeutics, Inc. | 19.94M | 0.85% | 318,659 | 9.78M |
| 519 | KAPA | Kairos Pharma, Ltd. | 19.91M | 2.66% | 517,417 | - |
| 520 | COEP | Coeptis Therapeutics Holdings, Inc. | 19.22M | 13.47% | 52,419 | - |
| 521 | IBO | Impact BioMedical Inc. | 18.98M | -0.41% | 9,046 | - |
| 522 | MEIP | MEI Pharma, Inc. | 18.39M | 2.60% | 11,567 | - |
| 523 | CARM | Carisma Therapeutics, Inc. | 18.37M | -3.25% | 125,111 | 20.27M |
| 524 | CLDI | Calidi Biotherapeutics, Inc. | 17.71M | 3.52% | 1,884,708 | - |
| 525 | SNTI | Senti Biosciences, Inc. | 17.67M | 1.05% | 13,914 | - |
| 526 | AFMD | Affimed N.V. | 17.62M | 0.47% | 85,319 | 6.29M |
| 527 | NKGN | NKGen Biotech, Inc. | 17.54M | 3.40% | 82,316 | - |
| 528 | BTAI | BioXcel Therapeutics, Inc. | 17.17M | -3.00% | 621,792 | 2.28M |
| 529 | CRVO | CervoMed Inc. | 17.09M | -2.82% | 31,329 | 10.07M |
| 530 | NNVC | NanoViricides, Inc. | 16.79M | -0.85% | 237,493 | - |
| 531 | BCTX | BriaCell Therapeutics Corp. | 16.63M | -3.85% | 401,154 | - |
| 532 | SYBX | Synlogic, Inc. | 16.56M | 0.40% | 11,162 | 2.78M |
| 533 | MTVA | MetaVia Inc. | 16.54M | -4.00% | 22,099 | - |
| 534 | GLYC | GlycoMimetics, Inc. | 16.07M | -0.76% | 131,271 | 10.00K |
| 535 | HCWB | HCW Biologics Inc. | 16.02M | 5.02% | 87,830 | 3.50M |
| 536 | XTLB | XTL Biopharmaceuticals Ltd. | 15.55M | -1.14% | 1,314 | 46.00K |
| 537 | IPA | ImmunoPrecise Antibodies Ltd. | 15.42M | - | 148,862 | 17.27M |
| 538 | CING | Cingulate Inc. | 15.39M | 3.68% | 54,927 | - |
| 539 | SPRB | Spruce Biosciences, Inc. | 15.00M | -2.23% | 144,370 | 7.10M |
| 540 | NERV | Minerva Neurosciences, Inc. | 14.96M | -0.47% | 3,250 | - |
| 541 | PHGE | BiomX Inc. | 13.99M | 4.18% | 10,880 | - |
| 542 | IMNN | Imunon, Inc. | 13.04M | 0.68% | 50,001 | - |
| 543 | BRTX | BioRestorative Therapies, Inc. | 12.25M | -2.21% | 36,552 | 377.00K |
| 544 | APTO | Aptose Biosciences Inc. | 12.23M | -0.94% | 390,784 | - |
| 545 | SNSE | Sensei Biotherapeutics, Inc. | 12.20M | -3.21% | 288,680 | - |
| 546 | LYRA | Lyra Therapeutics, Inc. | 12.11M | -2.22% | 1,338,028 | 1.47M |
| 547 | AIM | AIM ImmunoTech Inc. | 12.11M | -1.09% | 569,762 | 190.00K |
| 548 | RLMD | Relmada Therapeutics, Inc. | 12.01M | -0.52% | 188,229 | - |
| 549 | BCLI | Brainstorm Cell Therapeutics Inc. | 11.92M | 2.45% | 16,874 | - |
| 550 | IMRN | Immuron Limited | 11.91M | 1.73% | 10,235 | 3.27M |
| 551 | CSCI | COSCIENS Biopharma Inc. | 11.91M | -5.53% | 4,095 | 4.83M |
| 552 | ACXP | Acurx Pharmaceuticals, Inc. | 11.88M | 0.57% | 109,416 | - |
| 553 | HOTH | Hoth Therapeutics, Inc. | 11.29M | 5.48% | 980,589 | - |
| 554 | CANF | Can-Fite BioPharma Ltd. | 11.27M | -2.78% | 55,120 | 667.00K |
| 555 | APLM | Apollomics, Inc. | 11.26M | 0.89% | 8,661 | 2.10M |
| 556 | EVGN | Evogene Ltd. | 10.89M | 1.44% | 12,715 | 7.48M |
| 557 | PMCB | PharmaCyte Biotech, Inc. | 10.52M | - | 4,016 | - |
| 558 | TSBX | Turnstone Biologics Corp. | 10.43M | -3.40% | 64,081 | - |
| 559 | CLRB | Cellectar Biosciences, Inc. | 10.41M | -8.29% | 1,208,049 | - |
| 560 | JAGX | Jaguar Health, Inc. | 10.24M | -3.10% | 307,008 | 10.48M |
| 561 | BCDA | BioCardia, Inc. | 10.13M | 0.91% | 31,232 | 71.00K |
| 562 | PPBT | Purple Biotech Ltd | 10.11M | -0.83% | 24,154 | - |
| 563 | KPRX | Kiora Pharmaceuticals, Inc. | 10.08M | 4.67% | 35,434 | 16.02M |
| 564 | CDT | Conduit Pharmaceuticals Inc. | 9.88M | -10.43% | 16,952,150 | - |
| 565 | VRAX | Virax Biolabs Group Limited | 9.33M | -6.21% | 175,651 | 84.87K |
| 566 | ENSC | Ensysce Biosciences, Inc. | 9.27M | 5.19% | 11,871 | 4.42M |
| 567 | INDP | Indaptus Therapeutics, Inc. | 8.95M | -2.50% | 24,348 | - |
| 568 | KLTO | Klotho Neurosciences, Inc. | 8.78M | -3.95% | 68,611 | - |
| 569 | ICU | SeaStar Medical Holding Corporation | 8.12M | -4.71% | 661,600 | 68.00K |
| 570 | SILO | Silo Pharma, Inc. | 7.80M | -3.33% | 463,192 | 72.10K |
| 571 | CYCN | Cyclerion Therapeutics, Inc. | 7.66M | 3.60% | 31,251 | 194.00K |
| 572 | EYEN | Eyenovia, Inc. | 7.06M | -26.28% | 27,181,389 | 31.83K |
| 573 | PSTV | Plus Therapeutics, Inc. | 7.02M | 0.86% | 5,483 | 5.73M |
| 574 | VIRX | Viracta Therapeutics, Inc. | 6.70M | -0.71% | 607,083 | - |
| 575 | KZIA | Kazia Therapeutics Limited | 6.64M | -0.35% | 33,328 | 1.66M |
| 576 | APM | Aptorum Group Limited | 6.61M | -4.11% | 69,548 | - |
| 577 | ADXN | Addex Therapeutics Ltd | 6.58M | 3.87% | 14,274 | 701.26K |
| 578 | GRI | GRI Bio, Inc. | 6.57M | -1.87% | 115,318 | - |
| 579 | DOMH | Dominari Holdings Inc. | 6.53M | 0.97% | 14,435 | 12.59M |
| 580 | ABVC | ABVC BioPharma, Inc. | 6.51M | 2.96% | 43,686 | 509.79K |
| 581 | ELAB | PMGC Holdings Inc. | 6.48M | -8.66% | 167,536 | 2.45M |
| 582 | ADIL | Adial Pharmaceuticals, Inc. | 6.45M | -1.24% | 26,740 | - |
| 583 | CNSP | CNS Pharmaceuticals, Inc. | 6.40M | 3.82% | 10,320,147 | - |
| 584 | SYRS | Syros Pharmaceuticals, Inc. | 6.39M | 0.21% | 986,861 | 386.00K |
| 585 | GLTO | Galecto, Inc. | 6.35M | 0.84% | 2,154 | - |
| 586 | XBIO | Xenetic Biosciences, Inc. | 6.34M | - | 8,688 | 2.52M |
| 587 | ALZN | Alzamend Neuro, Inc. | 6.24M | 1.58% | 54,763 | - |
| 588 | GNPX | Genprex, Inc. | 6.17M | -1.76% | 271,463 | - |
| 589 | MBIO | Mustang Bio, Inc. | 6.15M | -10.36% | 6,399,764 | - |
| 590 | CMND | Clearmind Medicine Inc. | 6.13M | - | 43,348 | - |
| 591 | SNGX | Soligenix, Inc. | 5.75M | -12.26% | 444,044 | 364.18K |
| 592 | EDSA | Edesa Biotech, Inc. | 5.74M | 4.11% | 12,058 | - |
| 593 | GTBP | GT Biopharma, Inc. | 5.72M | 1.59% | 71,589 | - |
| 594 | CHRO | Channel Therapeutics Corporation | 5.57M | -1.84% | 9,659 | - |
| 595 | MBRX | Moleculin Biotech, Inc. | 5.49M | -4.19% | 23,200 | - |
| 596 | ONVO | Organovo Holdings, Inc. | 5.41M | -0.57% | 48,528 | 103.00K |
| 597 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.34M | -5.00% | 4,749 | - |
| 598 | PBM | Psyence Biomedical Ltd. | 5.10M | -7.69% | 143,326 | - |
| 599 | VINC | Vincerx Pharma, Inc. | 5.06M | -11.72% | 2,835,529 | - |
| 600 | CERO | CERo Therapeutics Holdings, Inc. | 4.95M | -7.86% | 224,810 | - |
| 601 | SNPX | Synaptogenix, Inc. | 4.73M | 9.06% | 2,850 | - |
| 602 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 4.57M | - | 56,605 | 18.63K |
| 603 | ALLR | Allarity Therapeutics, Inc. | 4.56M | 1.91% | 755,540 | - |
| 604 | PRTG | Portage Biotech Inc. | 4.56M | -3.33% | 14,011 | - |
| 605 | ONCO | Onconetix, Inc. | 4.52M | -9.41% | 609,241 | 1.87M |
| 606 | AEON | AEON Biopharma, Inc. | 4.52M | -11.02% | 10,432,848 | - |
| 607 | PLRZ | Polyrizon Ltd. | 4.47M | -4.79% | 83,418 | - |
| 608 | TOVX | Theriva Biologics, Inc. | 4.40M | -17.28% | 224,124 | - |
| 609 | GLMD | Galmed Pharmaceuticals Ltd. | 4.37M | 2.84% | 8,960 | - |
| 610 | XRTX | XORTX Therapeutics Inc. | 4.36M | -22.31% | 596,495 | - |
| 611 | NCNA | NuCana plc | 4.24M | 1.94% | 28,245 | - |
| 612 | EVAX | Evaxion Biotech A/S | 3.81M | -12.63% | 189,357 | 3.30M |
| 613 | CELZ | Creative Medical Technology Holdings, Inc. | 3.79M | 0.70% | 8,720 | 11.00K |
| 614 | BPTH | Bio-Path Holdings, Inc. | 3.78M | 4.56% | 109,219 | - |
| 615 | SLRX | Salarius Pharmaceuticals, Inc. | 3.73M | -1.89% | 454,266 | - |
| 616 | ARTL | Artelo Biosciences, Inc. | 3.71M | 1.77% | 21,193 | - |
| 617 | LIPO | Lipella Pharmaceuticals Inc. | 3.71M | -0.11% | 10,320 | 483.53K |
| 618 | ATXI | Avenue Therapeutics, Inc. | 3.65M | 1.60% | 5,119 | - |
| 619 | OGEN | Oragenics, Inc. | 3.58M | -1.08% | 129,136 | - |
| 620 | TCBP | TC Biopharm (Holdings) Plc | 3.52M | -6.78% | 865,615 | - |
| 621 | ENVB | Enveric Biosciences, Inc. | 3.51M | -3.71% | 91,819 | - |
| 622 | ZVSA | ZyVersa Therapeutics, Inc. | 3.40M | -2.68% | 215,495 | - |
| 623 | NBY | NovaBay Pharmaceuticals, Inc. | 3.37M | -2.95% | 53,987 | 13.84M |
| 624 | TNFA | TNF Pharmaceuticals, Inc. | 3.36M | -17.57% | 1,323,962 | - |
| 625 | NLSP | NLS Pharmaceutics AG | 3.23M | -1.97% | 124,619 | - |
| 626 | ATNF | 180 Life Sciences Corp. | 3.17M | 2.88% | 113,855 | - |
| 627 | HEPA | Hepion Pharmaceuticals, Inc. | 3.13M | -5.26% | 37,254 | - |
| 628 | PTIX | Protagenic Therapeutics, Inc. | 3.13M | 0.92% | 140,462 | - |
| 629 | KTTA | Pasithea Therapeutics Corp. | 3.12M | -1.20% | 23,662 | - |
| 630 | INM | InMed Pharmaceuticals Inc. | 3.07M | 2.27% | 11,051 | 4.96M |
| 631 | THAR | Tharimmune, Inc. | 2.99M | 2.55% | 4,917 | - |
| 632 | SCNI | Scinai Immunotherapeutics Ltd. | 2.96M | 0.68% | 3,292 | 452.00K |
| 633 | MTNB | Matinas BioPharma Holdings, Inc. | 2.96M | -17.00% | 585,564 | - |
| 634 | QLGN | Qualigen Therapeutics, Inc. | 2.95M | -1.47% | 9,192 | - |
| 635 | DWTX | Dogwood Therapeutics, Inc. | 2.92M | -0.45% | 7,069 | - |
| 636 | TTNP | Titan Pharmaceuticals, Inc. | 2.92M | 0.96% | 17,629 | - |
| 637 | PHIO | Phio Pharmaceuticals Corp. | 2.85M | -24.59% | 3,440,580 | - |
| 638 | QNRX | Quoin Pharmaceuticals, Ltd. | 2.83M | -1.68% | 135,726 | - |
| 639 | TCRT | Alaunos Therapeutics, Inc. | 2.83M | -1.67% | 4,451 | 7.00K |
| 640 | DRMA | Dermata Therapeutics, Inc. | 2.78M | -5.56% | 57,672 | - |
| 641 | PCSA | Processa Pharmaceuticals, Inc. | 2.77M | 2.22% | 8,453 | - |
| 642 | SPRC | SciSparc Ltd. | 2.76M | 1.72% | 807,817 | 1.75M |
| 643 | ENTO | Entero Therapeutics, Inc. | 2.64M | -3.48% | 31,743 | - |
| 644 | SLXN | Silexion Therapeutics Corp | 2.60M | -8.47% | 131,188 | - |
| 645 | BDRX | Biodexa Pharmaceuticals Plc | 2.42M | -1.89% | 2,926 | 104.90K |
| 646 | CYCC | Cyclacel Pharmaceuticals, Inc. | 2.33M | -4.64% | 231,685 | 74.00K |
| 647 | PALI | Palisade Bio, Inc. | 2.31M | -0.57% | 86,430 | - |
| 648 | APVO | Aptevo Therapeutics Inc. | 2.22M | -2.31% | 29,448 | - |
| 649 | WINT | Windtree Therapeutics, Inc. | 2.22M | -1.12% | 20,124,566 | - |
| 650 | REVB | Revelation Biosciences, Inc. | 2.11M | 4.44% | 214,742 | - |
| 651 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.10M | 1.50% | 106,514 | 462.61K |
| 652 | ADTX | Aditxt, Inc. | 2.00M | 3.85% | 146,600,705 | 212.11K |
| 653 | AZTR | Azitra, Inc. | 1.91M | -40.50% | 4,271,017 | 97.50K |
| 654 | VRPX | Virpax Pharmaceuticals, Inc. | 1.69M | -0.75% | 123,140 | - |
| 655 | SCPX | Scorpius Holdings, Inc. | 1.69M | 3.97% | 479,155 | 10.04M |
| 656 | RNAZ | TransCode Therapeutics, Inc. | 1.57M | -10.42% | 95,979 | - |